<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03542526</url>
  </required_header>
  <id_info>
    <org_study_id>LVHTN</org_study_id>
    <nct_id>NCT03542526</nct_id>
  </id_info>
  <brief_title>Relationship of Different Electrocardiographic Parameters and Ambulatory Blood Pressure Parameters to Detect Left Ventricular Hypertrophy</brief_title>
  <official_title>Relationship of Different Electrocardiographic Parameters and Ambulatory Blood Pressure Parameters to Detect Left Ventricular Hypertrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To review the accuracy of electrocardiography in screening for left ventricular hypertrophy
      in patients with hypertension.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Arterial hypertension is a major cause of coronary heart disease, stroke, and heart failure.
      Several studies have shown that left ventricular hypertrophy is an important risk factor in
      patients with hypertension, leading to a fivefold to 10-fold increase in cardiovascular
      risk,1 2 3 4 5 which is similar to the increase seen in patients with a history of myocardial
      infarction.6 The presence of left ventricular hypertrophy, in addition to hypertension, thus
      has important implications for assessing risk and managing patients, including decisions on
      interventions other than antihypertensive treatment, such as lipid lowering treatment and
      lifestyle modifications.7 8 Accurate and early diagnosis of left ventricular hypertrophy is
      therefore an important component of the care of patients with hypertension.

      Decisions about treatment should be based on assessments of hypertensive target organ damage
      and overall cardiovascular risk. The appropriate diagnostic work-up of suspected left
      ventricular hypertrophy in patients with hypertension is less clear, however. There is many
      electrocardiographic indexes for the diagnosis of left ventricular hypertrophy, based on the
      standard 12 lead electrocardiogram, have been described. Many of the proposed indexes have
      remained anecdotal, but others are commonly used, including the Sokolow-Lyon index,9 the
      Cornell voltage index,10 the Cornell product index,11 the Gubner index,12 and the
      Romhilt-Estes scores.13 However, debate about their comparative diagnostic value continues.14
      15 We did a systematic review to clarify the accuracy of different electrocardiographic
      indexes, with emphasis on their ability to rule out left ventricular hypertrophy in patients
      with arterial hypertension.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>minimize complicate of hypertension</measure>
    <time_frame>1 years</time_frame>
    <description>screening with hypertensive patient</description>
  </primary_outcome>
  <enrollment type="Anticipated">73</enrollment>
  <condition>Hypertension</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>electrogradiogram</intervention_name>
    <description>12 lead ecg ambulatory blood prussre</description>
    <other_name>blood measuring device</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ambulatory blood prussre</intervention_name>
    <description>ambulatory blood pressure to measure blood pressure</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All eligible patients attending the Hypertension outpatient clinic over two year duration
        starting from November 2018, will be consecutively enrolled
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients ranging from 20t o 80 years attending the hypertension outpatient clinic for
        ambulatory blood pressure measurement will be consecutively enrolled

        Exclusion Criteria:

          1. Patients with ischemic heart disease.

          2. Patients with advanced respiratory, renal, or hepatic disease

          3. Patients with uninterpretable ECG or ABPM recordings
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yehia t Keshk, professor</last_name>
    <phone>20882335120</phone>
    <email>yehia@aun.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tarek a nagib, lecturer</last_name>
    <phone>201099975128</phone>
    <email>Tarkaf76@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>AssiutU</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yehia T Keshk, professor</last_name>
      <phone>20882335120</phone>
      <email>yehia@aun.edu.eg</email>
    </contact>
    <contact_backup>
      <last_name>Tarek a nagib, lecturer</last_name>
      <phone>201099975128</phone>
      <email>Tarkaf76@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856691/</url>
    <description>Diagnostic and Prognostic Utility of ECG for Left Ventricular Hypertrophy Defined by MRI in Relationship to Ethnicity: The Multi-Ethnic Study of Atherosclerosis (MESA)</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001078/</url>
    <description>Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review</description>
  </link>
  <link>
    <url>https://en.wikipedia.org/wiki/Ambulatory_blood_pressure</url>
    <description>Ambulatory blood pressure</description>
  </link>
  <reference>
    <citation>Jain A, Tandri H, Dalal D, Chahal H, Soliman EZ, Prineas RJ, Folsom AR, Lima JA, Bluemke DA. Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2010 Apr;159(4):652-8. doi: 10.1016/j.ahj.2009.12.035.</citation>
    <PMID>20362725</PMID>
  </reference>
  <reference>
    <citation>Pewsner D, Jüni P, Egger M, Battaglia M, Sundström J, Bachmann LM. Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. BMJ. 2007 Oct 6;335(7622):711. Epub 2007 Aug 28. Review.</citation>
    <PMID>17726091</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>March 27, 2018</study_first_submitted>
  <study_first_submitted_qc>May 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2018</study_first_posted>
  <last_update_submitted>May 20, 2018</last_update_submitted>
  <last_update_submitted_qc>May 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Michael Sadeq</investigator_full_name>
    <investigator_title>cardiology resident, principle investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertrophy, Left Ventricular</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>to maintain the privacy of the protocol</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

